LogoPressRelease.jpg
Fluidigm to Participate at Upcoming Investor Events in September
September 05, 2018 18:00 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, announced today that the company’s...
LogoPressRelease.jpg
Fluidigm Announces Second Quarter 2018 Financial Results
August 02, 2018 16:05 ET | Fluidigm Corporation
Total revenue increases 11 percent to $26.4 million Mass cytometry revenue growth of 32 percent Total consumables revenue growth of 19 percent SOUTH SAN FRANCISCO, Calif., Aug. 02, 2018 (GLOBE...
LogoPressRelease.jpg
Fluidigm Announces Conference Call and Webcast of Second Quarter 2018 Financial Results
July 05, 2018 16:05 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., July 05, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative life science company that develops, manufactures and markets multiparameter mass...
LogoPressRelease.jpg
Fluidigm to Participate in Upcoming Investor Events
May 09, 2018 16:05 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative life science company that develops, manufactures and markets multiparameter mass...
LogoPressRelease.jpg
Fluidigm Introduces High-Parameter Maxpar Immune Monitoring Panel for Translational and Clinical Research
April 13, 2018 16:10 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., April 13, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of the Maxpar® Human Immune Monitoring Panel Kit for comprehensive...
LogoPressRelease.jpg
Fluidigm Announces Agreement With the University of Zurich to Distribute histoCAT for Multiparameter Imaging Mass Cytometry Data Analysis
October 24, 2017 08:10 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it has entered into a distribution agreement with the University of Zurich to...
LogoPressRelease.jpg
European Mass Cytometry Consortium Brings CyTOF Technology to Leading Universities to Advance Clinical Research
May 04, 2017 16:10 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that leading research institutions in the UK have partnered to acquire and implement...
LogoPressRelease.jpg
Fluidigm Announces First Quarter Financial Results
May 04, 2017 16:05 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the first quarter ended March 31, 2017. Total revenue...
LogoPressRelease.jpg
Nicolas Barthelemy and Carlos Paya Join Fluidigm Board of Directors
March 27, 2017 16:05 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., March 27, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that Nicolas Barthelemy and Dr. Carlos Paya have been appointed to its Board of...
LogoPressRelease.jpg
Fluidigm Announces Preliminary Revenue for the Fourth Quarter and Full Year Ended December 31, 2016
January 09, 2017 16:15 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Jan. 09, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced preliminary revenue for the fourth quarter and full year ended December 31, 2016. ...